Table 3.
No 3D | 3D | P value | |
---|---|---|---|
No. of patients | 177 | 147 | |
Malignanta | 161(91.0) | 124 (84.4) | 0.069 |
Pathological stagea | <0.001 | ||
pT1a | 114 (64.4) | 93 (63.3) | |
pT1b | 46 (26.0) | 20 (13.6) | |
pT2 | 0 (0) | 7 (4.8) | |
pT3 |
1 (0.8) |
6 (4.1) |
|
NR | 16 (9.0) | 21 (14.3) | |
Tumor size at final pathologyc (mm) | 34.5, 30.0 (25.0; 40.0) | 35.4, 32.0 (24.0; 40.0) | 0.893 |
Positive surgical margina | 4 (2.3) | 2 (1.4) | 0.433 |
Histologya | 0.003 | ||
Clear cell carcinoma |
154 (87.0) |
113 (76.9) |
|
Angiomyolipoma | 8 (4.5) | 11 (7.5) | |
Papillary | 7 (4.0) | 6 (4.1) | |
Oncocytoma | 1 (0.6) | 7 (4.8) | |
Cromophobe | 0 (0.0) | 4 (2.7) | |
Unclassified | 5 (2.8) | 0 (0.0) | |
Other | 2 (1.1) | 6 (4.1) | |
ISUP gradea | 0.168 | ||
1 | 12 (7.5) | 16 (13.1) | |
2 | 115 (71.4) | 87 (71.3) | |
3 |
31 (19.3) |
19 (15.6) |
|
4 | 3 (1.9) | 0 (0.0) |
ISUP = International Society of Urological Pathology; a = no. (%); c = mean, median (interquartile range).